wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38404422-9382936C-B8E4-4F3A-88E2-EC508F1F2A9E
Q38404422-9382936C-B8E4-4F3A-88E2-EC508F1F2A9E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38404422-9382936C-B8E4-4F3A-88E2-EC508F1F2A9E
Which tyrosine-kinase inhibitor to use first in chronic phase chronic myelogenous leukemia?
P2860
Q38404422-9382936C-B8E4-4F3A-88E2-EC508F1F2A9E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38404422-9382936C-B8E4-4F3A-88E2-EC508F1F2A9E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
38c4135fe57d9f81540a31d707b3606ba694db31
P2860
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.